Covid Nasal Vaccine Gets Nod For Phase 2/3 Trials
Bharat Biotech has got a nod from the Central Drugs Standard Control Organisation(CDSCO) to conduct Phase 2/3 trials of its nasal Covid-19 vaccine. Phase 1...
Download Unicorn Signals App
Powered By EquityPandit
